Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1)

Seon Sook Kim1, Yohan Oh, Kwang Chul Chung

  • 1Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University, Chuncheon 200-701, Republic of Korea.

Insights

Protein kinase A (PKA) phosphorylates regulator of calcineurin 1 (RCAN1), increasing its expression and enhancing its function. This discovery sheds light on RCAN1 regulation in Alzheimer's disease and Down syndrome.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Regulator of calcineurin 1 (RCAN1) protein levels are elevated in Alzheimer's disease (AD) and Down syndrome (DS).
  • RCAN1 is encoded by the Down syndrome critical region 1 (DSCR1) gene.
  • The precise regulatory mechanisms controlling RCAN1 expression and function remain incompletely understood.

Purpose of the Study:

  • To investigate the role of protein kinase A (PKA) in the regulation of RCAN1.
  • To elucidate the impact of PKA-mediated phosphorylation on RCAN1 expression and function.
  • To explore the implications for calcineurin-mediated gene transcription.

Main Methods:

  • In vitro and in vivo phosphorylation assays of RCAN1 by PKA.
  • Pharmacological inhibition of PKA using H-89.
  • siRNA-mediated knockdown of the PKA catalytic subunit.
  • Analysis of RCAN1 protein half-life and expression levels.
  • Assessment of RCAN1's inhibitory effect on calcineurin-mediated transcription.

Main Results:

  • PKA directly phosphorylates RCAN1 both in vitro and in vivo.
  • PKA-mediated phosphorylation increases RCAN1 expression by extending its protein half-life.
  • Inhibition or knockdown of PKA leads to decreased RCAN1 expression.
  • Phosphorylated RCAN1 exhibits enhanced inhibition of calcineurin-mediated gene transcription.

Conclusions:

  • PKA is a key regulator of RCAN1 function through direct phosphorylation.
  • PKA-dependent phosphorylation stabilizes RCAN1, increasing its expression and activity.
  • These findings establish PKA as a critical component in the regulatory network controlling RCAN1.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...